BREAKING NEWS

BeyondSpring announces submission of New Drug Application (NDA) to U.S. FDA and China NMPA for Plinabulin and G-CSF combination for the prevention of chemotherapy-induced neutropenia (CIN).
Read more

09.18.2019

BeyondSpring Second-Quarter 2019 Financial Results and Operational Update

View Webcast